WinstonWınston
Fisher & Paykel Healthcare Corporation Limited logo

Fisher & Paykel Healthcare Corporation Limited

FPH.NZ
66
Medical - Instruments & Supplies · Healthcare
Price
NZ$42.24
+0.54 (+1.29%)
Market Cap
NZ$24.81B
Exchange
New Zealand Exchange
Winston Score
66
Winston is curious
A decent business — some strong pillars, some weaker.
Data as of Aug 10, 2026 · filings through Mar 31, 2026

Share count rising — dilution

+1.9% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 580.0M (2022) → 591.0M (2026)

Fisher & Paykel Healthcare is a New Zealand company that makes medical devices used to help people breathe. Its main products are humidifiers, breathing circuits, and masks used in hospitals and at home — especially for patients with respiratory problems or sleep apnea. The company is one of the world's leading makers of respiratory humidification systems, and its products are used in intensive care units and sleep clinics across the globe.

The company sells its hardware and the consumable parts that go with it — like tubes and masks that need regular replacement — which creates a steady, recurring stream of revenue. Fisher & Paykel operates in over 120 countries, with major markets in the US, Europe, and Asia-Pacific, and generates roughly NZD 2 billion in annual revenue. Its strong gross margins reflect a durable competitive position built on proprietary technology and deep hospital relationships. The key growth driver is rising global demand for respiratory care, though currency fluctuations and competition from larger medical device companies remain ongoing risks.

Winston Score History

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+25.1% YoY

YoY Growth Rate

Revenue accelerating

EPS Growth

+25.7% YoY

YoY Growth Rate

Strong earnings growth

R&D Spend

$236M/ year

Rising (+12% vs prior year)

10.1% of revenue

Below sector average (18%)

Investing heavily in future products and technology

Insider Activity

0.4%ownership

Relatively low insider ownership

Cash Position

Cash flow positive

$510M cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Company generates more cash than it spends — no dilution risk from fundraising

Revenue accelerating

Fisher & Paykel Healthcare Corporation Limited grew revenue 25% year-over-year and the growth rate is speeding up. That's the kind of momentum growth investors look for — the question is whether margins can follow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
64.8%
Premium pricing power — 64.8% gross margin
Operating Margin
29.8%
Excellent — 29.8% operating margin
ROCE
17.0%
Strong — 17.0% return on capital

ROIC between 15% and 25%. Every dollar invested in the business earns 15 to 25 cents back per year.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
+26.4%
Fast-growing sales (+26.4% YoY)
EPS YoY
+35.6%
Earnings growing fast (+35.6% YoY)

Earnings growing 25%+ a year. The compounder zone.

EPS Consistency
5/8 quarters
Mixed — about half the quarters showed growth

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
142%
Turns 142% of profit into real cash
FCF Margin
21.0%
Converts sales into free cash efficiently (21.0%)

Free cash flow margin above 20%. Out of every $100 in sales, more than $20 is real cash they keep.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
0.03
Conservative — low debt load (0.03)
Interest Cover
64.76x
Comfortably covers interest (64.8x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
52.8x
Expensive — P/E 52.8

P/E over 35. The market is pricing in heavy, sustained growth.

P/E vs Forward
+13.8
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (52.8 → 39.0)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend Yield
1.32%
Small dividend — 1.32% yield

Modest yield. The bulk of any return needs to come from price appreciation.

Dividend Growth
-11.2%
Dividend cut (-11.2% YoY) — warning sign

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial